Diabetic retinopathy in African–Americans with end-stage kidney disease: a cross-sectional study on prevalence and impact on quality of life
Authors' conclusion
DR is present in 75% of AA patients with diabetes and ESKD on haemodialysis. ESKD has a significant burden on general health and QoL; however, DR has a minor additional impact on the overall physical health and QoL in people with ESKD.
Study context
- Population
- African-American adults with diabetes and end-stage kidney disease (ESKD) undergoing dialysis
- Participants
- 93 adults
- Exposure
- Diabetic retinopathy (DR) vs no DR
- Outcome
- Prevalence of DR
Main finding
As reported in the abstract
Prevalence of DR
75%
Mild DR
33%
Moderate DR
9.6%
Severe DR
57.4%
Observational data: associations, not effects.
Further findings
Visual acuity
- Normal visual acuity
- 43%
- Moderate visual impairment
- 45%
- Severe visual impairment
- 12%
Physical health and quality of life (QoL), DR vs no DR
- Presence of DR had no significant impact on physical health and QoL vs participants without DR
Disease burden, SDoH and QoL in ESKD
- High burden of disease, multiple SDoH challenges, and low QoL and general health among patients with ESKD
Original publication
Diabetic retinopathy in African–Americans with end-stage kidney disease: a cross-sectional study on prevalence and impact on quality of life. BMJ Open Diabetes Res Care. Published 4 July 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →